StemCell Therapy

Leave a Legacy SupplementChai Brady speaks to Sightsavers about the devastating diseases and blindness they combat

Easily treated diseases that are now quickly tackled in the Western world with readily available medicines are still a scourge in developing countries, with blindness being one of the devastating outcomes.

Charlie Lamson, CEO of Sightsavers, told The Irish Catholic that it wasnt so long ago that countries like Ireland were struggling with diseases, such as Trachoma, easily treatable at its early stage with antibiotics.

Returning from Senegal recently, Mr Lamson saw first-hand the effects of Trachoma, and how the horrific disease develops. Working in over 30 countries the charity assist communities, governments and train local staff who will stay in the country helping those in need.

The way we work is a collaborative approach, the country office works with local partners and then works with the ministry of health, so a lot of what were doing is based on working directly with the countries, Mr Lamson says.

Were not just flying in, doing all this great stuff, and then flying out again. Its very much about working with government ministries to create genuine change in the way that they approach the challenges they have.

In 2018 the charity carried out more than 16 million eye examinations across the countries in which they work, and distributed more than 113 million treatments to prevent and treat debilitating diseases.

Sightsavers first programmes began in the 1950s, starting in Kenya, Uganda, Ghana, Malawi, Zimbabwe and Nigeria, with several other African countries following in the next two decades.

In the 1960s and 70s this was expanded into Asia with their first projects in India, Pakistan and Bangladesh. The charity also continued to extend their work across Africa. More recently, their work in Yemen began in 2018.

Their work in Sri Lanka came to an end in 2016, which was the first time the charity finished working in a country as they were satisfied that they eye care services they set up would continue without them.

Mentioning Francis Ford Coppolas film, The Godfather Part II, when fictional character Vito Corleones eyes are checked for Trachoma before he enters New York from Sicily, Mr Lamson says this is an example of how the Western world was once challenged with the disease.

All of the support thats provided to older people through a wealthy society, a modern economy, if you were to remove all of that and then find yourself in a very poor economy without any of those structures in place its very devastating.

Trachoma is the worlds leading infectious cause of blindness, and is part of a group of conditions known as neglected tropical diseases (NTDs). Much like conjunctivitis it starts as a bacterial infection, but if it is not treated it can become unbearable.

Over time it causes scarring to the eyelid that pulls the eyelashes inward, so with every blink they scrape against the eye. This advanced form is called trichiasis and is so intensely painful that people afflicted resort to pulling out their eyelashes due to the agony of blinking.

The disease thrives where there are water shortages, poor sanitation and infestations of flies. Its caused byrepeated infection with bacteriaknown as chamydia trachomatis, and it spreads through contact with infected flies and via hands, clothes or bedding that have been in contact with an infected person.

Mr Lamson says they are working on a campaign called The End is in Sight, which endeavours to eliminate the disease by 2025. Currently there are still 44 countries that count the disease as a public health problem.

We train ophthalmologists, ophthalmic surgeons, ophthalmic nurses, were working with ministries of health around things like budgeting and long term planning, all of these, he says.

The result of this will be a trained medical professional from the country who will stay there and continue to work with people. In addition to training, they provide expertise and medical equipment, with Mr Lamson saying the model is based on true sustainable development.

***

Trachoma is not the only disease the charity is combatting. River blindness is a parasitic infection spread by flies near fast flowing rivers and can cause severe irritation, itching and even blindness if the infection is not treated.

Mr Lamson says: Were not working directly with river blindness in Senegal, although we do see it for example in Ghana. One of my colleagues was down there and has unbelievable stories.

You see a whole village river blindness can affect up to 70% of a community when it really takes hold, and 40 years ago that would be the case. She visited a community in Ghana and was interviewing seniors within the community. She interviewed about five or six people, all of them were blind as a result of river blindness.

The community his colleague visited had to abandon their former village to move further away from the river, due to the prevalence of river blindness.

The community was dying, the young people all moving away, you were left with a lot of visually impaired seniors in the community so it was devastating, to see the pictures and hear her talk about it, he says.

River blindness is interesting because it can take years for it to manifest before it then starts to manifest in the eye and cause vision loss.

When someone is bitten by the flies, larvae invade the body and develop into worms that can live for 15 years. Female worms produce thousands of microscopic larvae each day known as microfilariae which spread through the body and can be passed on to others. When the microfilariae die, they cause a reaction leading to immense irritation, inflammation and itching. If the larvae travel to the eyes, it can cause irreversible sight loss.

As well as pain, blindness and the associated stigma, river blindness forces people to move away from fertile river valleys where the disease is prevalent. As a result, they can struggle to find suitable areas to farm or grow crops, pushing families and communities into poverty.

However, treatment is relatively cheap, with Mr Lamson saying 50 can protect 1,000 people from river blindness. The medication comes in the form of tablets and a simple method used to gauge the height of a person informs what dose someone should be given.

Almost all of usare going to be disabled, and the majority are going to face that disability when we get to that age in our lives, when were older

The instrument is called a dose pole, which is tall and colourful, with each colour having dots representing how many tablets should be given depending on a persons height.

For example if a person is 172cm, the dose pole would be placed beside them and would show they need three tablets. Due to some community members being wary of the medicines, Mr Lamson explains, having community directed distributors (CDDs) is a huge benefit.

People from within the community are each given a dose pole, which is easy to use regardless of literacy levels, and they can be trained and subsequently trusted to treat other members of the community properly.

The added benefit is the distributors are nominated by their local community and are therefore ideally placed to deliver the medication as they understand the communitys dynamics and customs, enabling Sightsavers to deliver aid to those who need help the most and ensure that people in the most poor or remote areas are treated.

***

One of the most vital parts of the charitys ability to continue with these, and other life-changing initiatives is through their legacy donations.

Legacy donations are critical, its a huge part of our work. Oftentimes a legacy giftwe can use in the areas that we need it most, which is really important, says Mr Lamson.

Its such a personal form of support for us. We recently have a number of legacy gifts come through and weve ended up getting some absolutely incredible letters from the family who are talking about the person who had passed away and how this was important for them, in that they had wanted to do something and they had chosen us because they had known something about us. Or theyd been giving to us for years as a regular donor, and theyd receive our correspondence.

A lot of what were trying to do is tell people about what it is that were doing. Whats wonderful to me is that a lot of people feel moved by that enough and trusting enough of the work that were doing.

Reflecting on the disparity of opportunity and affluence between the Western world and developing countries such as the ones the charity works with in West Africa, Mr Lamson says since he started with Sightsavers two years ago it really struck him how eye glasses in Senegal are not common the percentage of people who have them is extremely low and in rural communities its almost zero.

I do a fair number of presentations and things like that, and if Im sitting with an audience, and I were to ask everyone to take off their glasses, half the audience wouldnt be able to see the presentation, he said.

You think about the impact of eye glasses, how we take them so much for granted, and if you were suddenly to say none of us could have eye glasses the impact on our lives at a personal level, on the community where we live, on the whole functioning of our society. If you were to remove the capacity of people who need eye glasses to get through the day thats a big one.

Almost all of us at some point in our lives are going to be disabled, and the majority are going to face that disability when we get to that age in our lives, when were older.

Sightsavers also do large amounts of work to promote inclusive societies for the disabled, whether in education, employment, healthcare or politics.

In Senegal the charitys inclusive education pilot project was launched in three schools in Dakar in 2014. Part of this was to work with the General Directorate of Social Action to provide scholarships to blind students, they also give financial assistance to parents, translate textbooks to braille, adapt school facilities, certify children as visually impaired and provide eye care through the Senegal eye care programme, including low vision aids, braille and referrals for treatment such as cataract surgery, to name a few.

If youre talking about an underdeveloped economy like Senegal, where you have 54% illiteracy and then you throw on top of that those who are disabled, or have a vision impairment then you really are at the end of the line there, so were trying to work with those guys, Mr Lamson added.

While Sightsavers work in a variety of countries across the world, at times some communities and societies are in greater need of immediate action to mitigate harm. Legacy donations, Mr Lamson explains, help the charity to pour resources and initiate positive change quickly; protecting eyes against blindness and disease and combatting exclusion because of disability.

Related

See the rest here:
An end to Trachoma blindness is in sight - The Irish Catholic

Brittany Howards new album, Jaime, is her first solo effort. The project takes its name and inspiration from her older sister, who died in 1998 after a battle with retinoblastoma, a disease Howard herself has dealt with, causing partial blindness in one eye.

The singer, now 31, was inspired by her sister to write poetry and play music. And she has made a life of it.

After two hugely successful albums with Alabama Shakes, Howard who plays Denver on November 14 and Boulder on November 15 has blossomed with Jaime, which is genre-defying, powerful and at times downright funky and fun.

Westword caught up with her to discuss her tour and the new album.

Westword: I saw this video of you saying how excited you are about this tour, and as the camera zoomed out, you were getting a mani and a pedi at the same time.

Brittany Howard: [Laughs.] Oh, yeah, sometimes that happens. You know, we treat ourselves every once in a while.

How important is it to have a sense of humor on the road, with all the stress?

Massively important. Otherwise, who knows what could happen? Its super-important for anyones well-being.

Have you discovered the things on the road, over the years, that you should absolutely do and absolutely not do?

You should absolutely not go out every night after a show. Absolutely do drink lots of water and make sure you sleep a lot.

Youve played in Colorado quite a bit. Do you have a specific feeling about the area?

Yeah, the crowds are usually pretty cool in Denver; theyre a real chill, laid-back, cool bunch of open-minded people.

What was it like opening for Neil Young at Red Rocks?

That was one of my favorite shows ever. I got to meet Mr. Young and talk some. It was really cool.

The new album is obviously your first solo record. What were the biggest differences writing and recording as Brittany Howard rather than as Alabama Shakes?

Just the freedom to make whatever choices I want, whether theyre good choices or bad choices. Its just fun to make those choices and get to paint my own picture how I envision it, how I hear it. I think thats been the biggest difference, just steering my own ship. Touring, its been interesting because I play less guitar when Im on stage, so Ive been really exploring what its like to just be so open to a crowd when Im on stage. Its been new and cool.

I heard you were a big fan of AC/DC growing up. How did you discover that place where Bon Scott might meet Aretha Franklin or Nina Simone?

I think the cross-section would be just performing from a real place. You know, theres a difference between just performing and making tons of dough, and being a performer because your spirit needs to do it. I think thats the difference between something good and something great.

There seems to be a parallel between your new album and the new records by Sturgill Simpson and also St. Paul and the Broken Bones. These artists who come from a rootsy background and are now just shattering boundaries. How did you get to that place where virtually anything can be a Brittany Howard song?

I mean, Ive never liked musical boundaries, just because it puts a limit on what you can do creatively. If its fun to do a little concept record or whatever, then do it. If its fun to mix and match everything youve heard before, do it.

How do you carry where you come from with you on stage every night, and writing? How much Alabama do you keep with you?

Well, its always ingrained in me. I think, for me, I feel pretty empowered to come from Alabama, just because the history is so radical and challenging. For me, just existing came from overcoming those things, so Im very much proud to be an Alabamian and just stand on stage and say, Yeah, this is me. Im a pretty radical person, and I come from a place thats considered so conservative, backwards. But guess what? Im from there, so can it be all that you think it is? Its kind of neat in a way to be this sort of un-elected ambassador.

Do you feel like a role model for young black women who might not have seen a black woman with a guitar fronting a rock band before?

I could see how someone would think like that, just because Im different to see on a stage as far as media goes. You dont usually see someone who looks like me doing what I do. I think thats cool. Its something that I definitely wouldve appreciated, being younger, seeing something like that and being like, Oh, thats me! I have options for what I can do with my life. Its not up to anything I see on television. On the other hand, Im just walking around like everybody else; its not like I behave or act according to what anybody made for me. I think Im really just being the best self I can be for myself. If that inspires other people, then awesome. I really want them to do the same thing.

The new album was inspired by your late sister. Do you feel her presence on stage every night as you play these songs?

Yeah, I do especially when Im tired and I need a little extra strength. But then, also its a kind of everyday relationship when you lose somebody close to you. It doesnt mean theyre gone. Its not really how it works. Its not like the movies, you know? That presence is always with you, always trying to get you through whatever youre trying to get through. I live my life in my sisters presence and memory, so of course when I made this record, it only made sense to just say Thank you, you know?

Your favorite song with her was Dont Worry Be Happy, by Bobby McFerrin. Since she passed away, what new music have you heard that you think you would have bonded over?

I dont know probably anything I liked. She had really good taste. Im not sure if she wouldve gone the pop way or more the avant-garde way. Its hard to say.

So many people have heard you sing Hold On," and sometimes during powerful, trying times in their lives. Its an empowering statement, but it prompts the question, just how do you hold on?

I guess its different in every situation. I think a massive part of it is giving yourself a break, and feeling whatever it is youre going through. Just experience that and sit with that, knowing its not going to kill you to feel sad, or to feel down for a moment, because happiness is always kinda coming around. Its never permanent. Youre not alone in that, and its just a normal part of being a human being. Things can get easier. And also, I really believe things work out the way theyre meant to if we kinda stay out of the way, so to speak. Things sort themselves out eventually, no matter how painful the experience might be. I think you just gotta remember that and stand in awe of that, that we all have something to offer.

Brittany Howard, with Georgia Anne Muldrow, plays at 8 p.m. Thursday, November 14, at the Ogden Theatre. 935 East Colfax Avenue. For tickets and more information, go to ogdentheatre.com. Howard and Muldrow also play at 8:30 p.m. Friday, November 15, at the Boulder Theater, 14th Street, Boulder. For tickets and more information, go to bouldertheater.com.

Pittsburgh native Adam Perry is a cyclist, drummer and University of Pittsburgh and Naropa University alum. He lives in Boulder and has written for Westword since 2008.

Read the rest here:
Brittany Howard on Freedom and Taking a Break From Alabama Shakes - Westword

MOVIES

9:41 AM PST 11/6/2019byJohn DeFore

You've heard of face-blindness, the phenomenon in which a patient can't recognize the person in front of her without resorting to clues like the stranger's voice and clothing. That's an unbelievable but real affliction. But what about person-blindness, in which someone becomes completely unable to see a specific person in her life, or even to sense them in any other way? Buying into that unlikely conceit is the first of several tough hurdles to appreciating Love Is Blind, Monty Whitebloom and Andy Delaney's romance about a lovely, lonely girl who can't see how many people adore her. A pretty fable (the directors made music videos in the 1990s for the Spice Girls and Paula Abdul) that drowns in its own preciousness, it might have remained unreleased if not for a familiar cast including Matthew Broderick and Chloe Sevigny as the heroine's parents.

As far as Shannon Tarbet's Bessie knows, she only has one surviving parent, Broderick's Murray. She thinks her mother died long ago, and that Murray's continuing references to her are caused by dementia linked to Parkinson's disease. Sevigny's Carolyn calmly deals with being ignored, describing her daughter as a nutcase and seeming to know, deep down, that she caused this delusion herself by being a lousy mother.

If that sounds like a shaky assumption to make about a mental disorder, Jennifer Schuur's screenplay is even less convincing in its approach to autism. Bess has long been seeing a psychotherapist (Benjamin Walker's Farmer Smithson) who describes himself as "on the spectrum," and much of his behavior here is dubious. For instance, if those on the spectrum typically value rules as a way of navigating the world, it's unlikely Farmer would be unperturbed by the sexual advances his patient makes toward him. One often feels that autism is just another set-dressing quirk here, much like the silly decor (stacks of books used as an architectural feature, walls full of antique mirrors) in Farmer's office.

Romance-wise, Farmer is just the preordained loser of the film's contrived romantic triangle. Bess' real soulmate is, naturally (?), the only person other than her mother she can't see. Russell (Aidan Turner, of the Hobbit trilogy) is a rumpled hunk currently doing demolition work next door to Farmer's office. The pic presents him as suicidal, but again, his yearning for non-existence is just a useful romantic conceit, an adolescent way of indicating these two troubled souls were made for each other. Farmer takes Russell on as a patient and suggests Bess should start group therapy with him, talking to the stranger as if he were an invisible friend. After a while, she's able to hear the supportive things he says to her.

Occasionally, Whitebloom and Delaney seem to be influenced by an auteur who came to prominence around the time they started their careers: Hal Hartley, whose art house-beloved first films (set, like this one, just a commuter-train ride outside Manhattan) paired unlikely couples and didn't require conventionally realistic performances from their casts. If that's the case, they've missed the lessons those offbeat but thoughtful films had to teach. Here, affectation seems to be valued for its own sake, and love is something more talked about than understood.

Production company: LocomotiveDistributor: Uncork'd EntertainmentCast: Shannon Tarbet, Aidan Turner, Matthew Broderick, Chloe Sevigny, Benjamin WalkerDirectors: Monty Whitebloom, Andy DelaneyScreenwriter: Jennifer SchuurProducers: Alexis Alexanian, Lucy Barzun Donnelly, Alexandra PerryExecutive producers: Lottie Cooper, Peter Friedlander, Christopher GrayDirector of photography: Monty WhitebloomProduction designer: Javiera VarasCostume designer: Olivia MoriEditor: Alex KopitCasting directors: James Calleri, Erica Jensen

93 minutes

Go here to see the original:
'Love Is Blind' Review - Hollywood Reporter

The Kenya Society for the Blind has urged the government to set aside more funds towards the prevention of avoidable blindness in Kenya.

Out of the 10 million, blindness arises due to preventable and treatable conditions such as trachoma, diabetic retinopathy and glaucoma, among others. There is also a rising increase of cases of blindness from lifestyle diseases such as diabetes.

The Kenya Society for the Blind Chairman Mr. Samson Waweru said that over 750,000 Kenyans are visually impaired with an additional 331,000 being totally blind.

Of the ten million people at risk, about 7.5 Million are infected. We as a Society and other players in the visual impairment space only have a capacity to reach out to 1,700,00 people per year. More services ranging from simple eye screening and treatment of common eye ailments are needed to reduce and prevent blindness. 80 percent of those cases at risk are preventable, meaning four out of five people who are blind right now in Kenya dont have to be. They are blind because the eye care services did not reach them in time while others simply cannot access medical care. Said Mr. Waweru.

According to the World Health Organization World Report on Vision, at least 2.2 billion people globally have a vision impairment or blindness, of whom at least 1 billion have a vision impairment that could have been prevented or has yet to be addressed.

Since its inception in 1956, The Society has supported more than two million Kenyans living with visual disabilities through the promotion of their welfare, education, training and employment while assisting in the prevention and alleviation of blindness.

See the rest here:
Government urged to set aside funds towards prevention of blindness in Kenya - HapaKenya

FLORIDA

One of thebiggest astronomy events of the yearwill take place Monday. Its an event so rare that it wont happen again until 2032.

People across North America, South America, Europe, Africa and western Asia will be able to see Mercury pass directly between the Earth and the sun in an astronomical alignment known as a transit.

Transits happen only a few times per century and provide a unique opportunity to see a planet glide across the face of the sun.

People will have a few hours to observe the event, which starts at 7:30 a.m. EST and lasts until 1:00 p.m. EST. That means for people in the western time zones, the transit will already be underway when the sun comes up.

Similar to a total solar eclipse, spectators will need a solar filter to shield their eyes from the harmful rays from the sun. Looking at the sun without a solar filter can lead to permanent eye damage and, in some cases, blindness.

However, onlookers will need more than just a solar filter to see the Mercury transit.

Because Mercury is so small from our perspective on Earth, youll need binoculars or a telescope with a Sun filter to see it,NASA said.

It is imperative to have a certified solar filter on the part of the telescope where light enters. Wearing solar filters, such as solar eclipse glasses, and looking into the eyepiece of a telescope that is not outfitted with a filter of its own can still lead to irreversible eye damage.

The American Astronomical Society (AAS) says that the filters should comply with theISO 12312-2 international safety standard. This number should appear with the filters original packaging or on the filter itself.

People will need not only the right equipment to see the Mercury transit but also cloud-free weather.

The best viewing conditions will be across the central and southwestern United States where clear skies will lead to an uninterrupted field of vision.

Meanwhile, disruptive clouds may obscure the sun across much of the Pacific Northwest, Deep South and East Coast.

People that cannot see the Mercury transit for themselves due to poor weather canwatch the event live.

Folks that miss Mondays event will have to wait more than a decade for the next opportunity to see a Mercury transit, with the next one taking place on Nov. 13, 2032.

There is an even longer wait for the next Venus transit, which is sometimes referred to as a twice in a lifetime event.

Venus transits come in pairs that are separated by an extended period of time. Most recently, there were a pair of Venus transits on June 8, 2004, and June 5, 2012, with the next pair not taking place until Dec. 10, 2117, and Dec. 8, 2125.

For more information on the Mercury Transit, visit the 2019 Mercury Transit website here.

Follow this link:
Rare Mercury transit happens Monday; When to watch and how to protect your eyes - Wink News

I never thought I had it in me to become one of those crazy dog people. And then, in the spring of my freshman year, a three pound, all-black, three-quarter-Shih-Tzu-one-quarter-Yorkie puppy named Annie became my third sister.

I watched through FaceTime the night my family brought her home. My parents laid with Annie on the basement floor, near the stairs that, 16 years earlier, their first dog Tiffany a Shih Tzu that accompanied them from their first apartment to the birth of all three of their children fell down in her cataract-induced blindness. She died after a one-way trip to the vet. Both my mother and I were allergic, two kids were away at college and the imprint of Tiffanys paws had not yet faded from our carpet. Nevertheless, we welcomed a new dog into the family. And as I like to say it was the best thing to happen to the Krebs household since I was born.

But why? Why does this little now-13-pound salt-and-pepper animal make us so happy? Maybe its because she triggers our parental instincts. Maybe its because shes adorable, and maybe its because shes just so adorable. There are so many reasons why dogs make us happy. But frankly, we focus on the wrong ones.

Were nearing finals, so its only a matter of time before packs of golden retrievers are paraded through Bass Library as a 15-minute stress panacea. Its only a matter of time before cringe-inducing print-outs, adorned with a pup, Impact font and an Uncle-Sam-esque you can do it message line the walls of computer rooms. Its only a matter of time before a pre-packaged doggie yoga secularized meditation program pops up in the Good Life Center sandbox and cures us of all our problems forever.

At Yale, dogs have been instrumentalized as an agent and symbol of the corporate wellness industrial complex. But wait, what is the corporate wellness industrial complex anyway? And what does it have to do with our perfect little pooches? Let me explain.

Corporate wellness thrives on a categorical division of happiness, the belief that we can divvy ourselves up into little boxes our careers, relationships, impact, physical health, mental health, happiness, etc. Its everywhere, and its defined by a fundamental contradiction: the simultaneous belief that these boxes never touch, that the bad of one can never contaminate the good of another. And yet, the good of one box can make up for the bad of another box.

Its the same division that allows us to pat our friends on the back with the other hand on the hilt of a dagger, to give contemporary imperialists lifetime achievement awards because theyre actually really nice in person, to meditate before our interviews with sweatshop management firms. It is the version of happiness that believes we should change neither the things that make us miserable on a societal level nor our undying commitments to those things, but rather how efficiently we go about fulfilling those commitments. It has the moral and intellectual consistency of canine excrement.

But, seriously, on the topic of canine excrement. I was in flip flops, gym shorts and my sisters winter jacket. It was freezing and beginning to rain, but Annie didnt seem to mind. I was taking her out so she could use the bathroom, and she was hell bent on doing anything but. She pranced around the yard, smelled the grass shed smelled a thousand times before, rolled on her favorite tennis ball and looked at me like I was an idiot when I started talking to her, begging her to please, just please do her business.

Then it hit me. I, Eric Krebs, Yale University student, opinion columnist, self-centered rising star extraordinaire in all my intelligence and glory, was at the total mercy of a dog. The little creature that lives in my house, eats entire bowls of taco meat off the kitchen table and doesnt even read my column.

And I couldnt have been happier.

See, dogs force us to place our centers of gravity beyond ourselves. They force us out of bed when they want to play, they force us out of the house when they want to walk, and they force us to reconsider what we consider important. Amidst the breathing exercises, the gratefulness exercises and the exercise exercises, corporate wellness holds the atomized individual to be the fundamental unit of existence. The question, then, is confined to what you do with this autonomy. Of course, when we are atomized, we are most efficient. Were ready to up and leave for a job offer, were ready to isolate ourselves in pursuit of perfection, were all self-contained trees who can choose exactly when and where our branches reach out and touch other trees.

But thats not how trees work. This is something that I think both the corporate wellness and anti-corporate wellness crowds get wrong. The corporate wellness camp likes to think that were autonomous actors that are fundamentally rational, the anti-corporate wellness camp likes to think that were autonomous actors that are fundamentally emotional. Neither are totally wrong, but neither are right. We like to tell ourselves we are so much more than Yale and its metrics for success. Yes, we are more than Yale but were also less than it, so much smaller than its buildings and books and trees. And thats okay. Trees need more than branches. Trees need the forest lest the soil erodes.

Happiness does not come from 15-minute puppy study breaks. Happiness is not derived from self-centered, autonomous scheduling. Happiness is the ability to vest our centers of gravity beyond ourselves, not in one thing but in many. To care for the little animals that live in our houses and make us smile even if we dont know why. To care for the people who make us laugh and make life worth living. To care for the world around us the world that belongs to us, the world that we belong to.

Even the strongest trees sometimes face a storm and lose a branch or two. So, dont worry when your branches fall and hit the ground, you beautiful, solid redwood. A dog just might come along and find the stick of a lifetime.

ERIC KREBS is a junior in Jonathan Edwards College. His column runs on alternate Mondays. Contact him at eric.krebs@yale.edu.

Read the original here:
KREBS: This is your dog on wellness - Yale Daily News

OLYMPIC boxing legend Nicola Adams has retired at the age of 37.

The Lioness hangs up her gloves with an undefeated record and as the current WBO flyweight world champion.

3

Adams, who was born in Leeds, became the first openly LGBT athlete to win an Olympic boxing gold medal when she took top spot at London 2012.

And she repeated the feat at Rio 2016 - the same year she won the World Championships.

She penned an open letter to her local newspaper, the Yorkshire Evening Post, in which she revealed that continuing her in-ring career risked "irreparable damage and permanent vision loss".

Adams, whose last fight was in September, wrote: "I'm immensely honoured to have represented our country - to win double Olympic gold medals and then the WBO championship belt is a dream come true," she wrote.

"But it's not without taking its toll on my body, and aside from the expected aches and pains, I've been advised that any further impact to my eye would most likely lead to irreparable damage and permanent vision loss.

"It has been an honour to compete on the global stage, and it has been a privilege to fight against such remarkable athletes.

I'm immensely honoured... but boxing has taken its toll on my body

Whilst I am proud of my achievements, the unwavering belief from everyone in my corner is something I will appreciate for the rest of my life.

"To my wonderful team, I would not be the fighter I am today without your encouragement and understanding - what you have taught me goes beyond the ring.

Particularly special thanks go to the wonderful Alwyn Belcher, my coach and personal mentor of many years.

"Hanging up my gloves was always going to hard, but I have never felt luckier and I'm so immensely proud of how far the sport has come."

Adams won the vacant WBO belt against Isabel Milan in 2018, less than 18 months after he first professional bout, and bows out with an unbeaten professional record of five wins and one draw.

3

3

Live Blog

fighting talk Boxing news LIVE - All the latest news and updates

Revealed

PAUL OUT ALL THE STOPS KSI vs Logan Paul sold more pay-per-views than AJ's defeat to Ruiz

ED SCRATCHER Ed Sheeran lookalike 'tricks the world' during KSI's win over Logan Paul

NO JOSHING Haye urges Joshua to copy Lewis in Ruiz rematch - despite war of words

CLOONEY TUNES Fury says he is mistaken for George Clooney and Brad Pitt 'all the time'

LO BLOW Saunders and Canelo 'hold talks' over fight - but GGG trilogy could come first

She was also a nominee for the BBC Sports Personality award in 2012.

Adams, who once worked as an extra on Coronation Street and Eastenders, was awarded an OBE in the 2017 New Year Honours.

She was described as a "trailblazer, history-maker and legend" by Team GB.

Read this article:
Olympic boxing legend Nicola Adams retires aged 37 over blindness fears as undefeated world flyweight champion - The Sun

SALT LAKE CITY November is National Diabetes Awareness Month. More than 30.3 million Americans have diabetes, according to the CDC, and chances are you know someone or are someone with diabetes.

As a registered dietitian and certified diabetes educator, I've seen and heard how well-meaning family members, friends, co-workers and even strangers can unintentionally make judgmental comments to someone with diabetes that are based off of myths or stereotypes. Here are some common misjudgments people with diabetes receive, along with facts and advice on what could be said instead.

Trust me when I say people with diabetes are always thinking about what they are eating and are frequently made aware of things they "shouldn't" be eating. Simply because someone has diabetes doesn't ban them from eating certain foods ever again. They just have to make sure it fits into their overall eating plan, just like everyone else in the world does. Diabetes doesnt mean never eating sugar or carbs; it means balancing blood sugar levels with food, medications and physical activity.

Unless you are a part of their health care team it's best to avoid analyzing every food that passes their lips. Stop being the food police and offer support and positive encouragement instead. Make healthy food choices yourself and have healthy food options available when sharing a meal. Say something like, "Hey, I made this delicious soup, would you like some?"

I'll say this once: sugar does not cause diabetes! Diabetes is a complicated disease and has many risk factors. Type 1 diabetes is an autoimmune disease where your bodys immune system attacks the cells that make insulin. Genetics, environment and other unexplained compenents are postulated as risk factors for Type 1 diabetes and there is no known way to prevent it. Type 2 diabetes has many risk factors, including genetics, lifestyle, environment and other unknown factors. Although studies have shown that some people may be able to prevent or delay Type 2 diabetes through different means, there is no single cause for Type 2 diabetes.

Instead of postulating as to why someone has diabetes, show empathy and ask for understanding. Something along the lines of, "I don't know much about diabetes. Could you tell me some of what you know?" is a great place to start.

There is no good or bad kind of diabetes. You cannot base the severity of someone's disease simply from the medication they take. People with Type 1 diabetes have to take insulin every day in order to survive because their bodies are no longer able to make it. People with Type 2 diabetes still make insulin, however, the disease can change over time and along with that, the medication needs may change as well. Each person with diabetes is unique and works with their health care team to determine the best foods, activity and medications to keep their blood sugars in a healthy range.

Don't tell someone they are bad because of the medication they take. Try saying something more positive like, "Diabetes seems very complicated. I'm glad there are medications available to help keep you healthy."

This statement may not be ill-intended, but calling someone a diabetic labels them as their chronic disease. While some people with diabetes don't mind the terminology, others find it offensive or stigmatizing. Diabetes does not define people with it, they are much more than that.

Talk to your family member or friend as someone who is their own person who happens to have a chronic illness. Instead of labeling someone as diabetic say, I didnt know you have diabetes."

No need to start telling diabetes horror stories. People with diabetes are already very familiar with the possible complications of the disease. Numerous improvements in diabetes care have greatly decreased the rates of complications these days. By self-monitoring and working closely with their health care team, people with diabetes are able to live a full and healthy life without complications from the disease.

Instead of talking, try listening. Ask how their day was or say something like, "Tell me how your basketball game went yesterday."

Spouting off medical advice and nutrition claims you saw on the internet or overheard at the gym is ill-advised. While we wait in earnest for new advances in diabetes care and treatment, there is currently no known cure for diabetes. If fad diets and hyped-up supplements promoted as cures really worked, then there would be a lot less people with diabetes.

Some vitamins, minerals, herbs and other supplements may adversely interact with medications people with diabetes are already taking. But it's always best for them to talk with a member of their health care team before starting anything new. Unless you are your friend or family member's doctor, avoid giving medical advice. Instead, talk about the weather, the latest episode of your favorite TV show or give them a compliment on their new haircut.

Really not helping here. The reality for someone with diabetes is there's going to be some pokes and prods. Even if they have an insulin pump or continuous glucose monitor there will still be some lancets and needles involved. It isn't easy but I'm positive people with diabetes think living with some pokes is much better than the alternative.

Be grateful you dont have this trial in life, and provide support if your friend or family member appears they need it. "You are a strong and capable person. I'm glad you are my friend," is something nice to say instead.

Blood sugar levels are one of the major factors when deciding on a course of action for diabetes care and treatment. However, blood sugar levels do not indicate success or failure. They're one of many variables monitored to give feedback. Blood sugar levels can rise for a number of reasons some of which are beyond a person's control, such as stress and illness.

Avoid commenting on blood sugar levels unless you are asked. Instead of telling your friend they did something wrong, extend support and positive encouragement. Saying, "Is there anything I can do for you right now?" is a great way to do that.

About the Author: Brittany PoulsonBrittany Poulson is a Utah registered dietitian and certified diabetes educator. She shares her passion for health, food and nutrition on her blog, http://www.yourchoicenutrition.com, where she encourages you to live a healthy life in your unique way.

Editors Note: Anything in this article is for informational purposes only. The content is not intended, nor should it be interpreted, to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition; Any opinions, statements, services, offers, or other information or content expressed or made available are those of the respective author(s) or distributor(s) and not of KSL. KSL does not endorse nor is it responsible for the accuracy or reliability of any opinion, information, or statement made in this article. KSL expressly disclaims all liability in respect to actions taken or not taken based on the content of this article.

Read the original post:
What not to say to someone with diabetes (and what to say instead) - KSL.com

When Phil Southerland, now 37, was 7 months old, doctors told his parents he likely wouldnt live past the age of 25.

The baby was thirstier than normal, crying all the time, losing large amounts of weight, and struggling to breathe. One doctor first dismissed his condition as the flu, but a nurse noticed something important: fruity breatha tell-tale sign of diabetes, which occurs as a complication of uncontrolled high blood sugar.

The attending physician at time told my mom, Good newsyour son is going to live for now, but the bad news is, he has juvenile diabetes, Southerland, a resident of Atlanta, told Bicycling. They basically said heres your insulin, and good luck, he says.

His parents knew Southerlands life was in their hands. They squeezed urine from diapers to check glucose levels and pricked his toes 10-15 times a day to check his blood sugar.

As an infant, I was captive to my insulin, he says.

As he grew, his doctors always advised his parents that type 1 diabetesa condition where your pancreas doesnt make enough insulin, causing blood sugar to build up in your bloodstreamand sports were a no-no.

But his parents encouraged him to give it a try, and he got on his first bike at 4 years old. It marked the beginning of a lifelong passion for cyclingand the start of advocacy so that others with his same condition could find a respite in riding, too.

As Southerland got older, his love for riding seemed to fit with his diabetes.

When I was on the bike, I was normal. I didnt have to check my sugar, my insulinit was a great equalizer for me, he says. The bike made me feel freedom. It became an addiction.

It also influenced him to manage his diabetes better so he was able to get out and ride his best.

He developed a close relationship with riders at a local bike shop in his native Tallahassee, Florida, and started riding competitively. He competed in his first racemountain bikingat the age of 12, and by 14, he knew he wanted to be a serious bike racer. This meant he had to focus on managing his diabetes even more.

In the early stages, Id have to check my blood sugar 4-5 times an hour before we went out on rides to make sure my glucose high enough, and once I went out, I just had to go by feel, he says. I was always over preparedthe journeys were stuffed with food.

Soon, he started riding on roads, and completed his first road race at 16.

He attended the University of Georgia and was quickly adopted into Athenss strong cycling community. His teammates and competitors knew he had type 1 diabetes, something that at the time was a bit of a hush-hush disease.

It was there where he met one of his best friends, Joe Eldridge, who saw him checking his blood sugar before a race. Eldridge had diabetes too, but unlike Southerland, was not managing it properly.

I took it upon myself to get him to finally care, he says. Wed go on rides together, and I made bets with himwhoever had higher blood sugar pays for dinner. He bought my meals for a while, but one day, the tab was on me. He told me, Hey man, I just want you to know you saved my life. That was a big turning point for me. The bike brought us together, and I wondered what the bike could do for others with diabetes.

It was a catalyst for Southerland to start talking to other people with diabetes. Back in 2004, he said, it was a disease that you hidand was still a disease about what you could not do.

Despite how others viewed diabetes, Southerland didnt believe it to be a limiting factor. That belief was only strengthened during a 165-mile bike ride home over Christmas in 2004, when he found himself mulling over Lance Armstrongs impact on those with cancer.

It got me thinking, why not use the biking platform to unite people with diabetes, to inspire people to take control of it? he says.

At the time, Southerland was taking business classes at UGA, and during his final semester, he was assigned a project to create a real-life business plan. He decided to combine his love for biking and new passion for type 1 diabetes awareness with the creation of Team Type 1.

His goal? To assemble a full team of cyclists with type 1 diabetes.

In February 2005, a chance meeting at an Atlanta Starbucks led to his first investment.

I was working on my project, and a man named Daniel Hopkins started asking me about what I was working on. He said, What would you do if you had $400? I told him I would buy T-shirts, get business cards, Southerland said. He said, Kid, go start your business. He gave me $400 cash right then and there, and I drove straight to the bank and opened an account for Team Type 1.

He quickly ordered 100 Team Type 1 T-shirts, and called Daniel Hopkins to thank him again, only to find out the number didnt exist.

I sent him an email that bounced. I tried calling every Daniel Hopkins in the Atlanta phonebook. I never found the guy, he says.

To this day, he has copies of his bank statement from that $400 investment framed in his office.

With time, the team grew from two athletes to eight athletesincluding Joe Eldridge. They participated in clinical trials for continuous glucose monitors so they could monitor their blood sugar levels throughout their rides and take out the guesswork.

Then, in 2006, they competed in their first Race Across America, a 3,000-mile race across the United States, which the team used to raise awareness. When Team Type 1 arrived at the start, they were viewed as the charity team. Five days, 16 hours and four minutes later, they finished second overall. A year later, they arrived smarter in their diabetes management and were the competition to beat.

Five days, 15 hours and 43 minutes later, Team Type 1 won the Race Across America and at the time set a new record for fastest time. (They repeated wins again in 2009 and 2010).

In 2008, they became a professional team and had earned UCI Professional Continental status by 2011. Team Type 1 ran a mixed squad of diabetic and non-diabetic riders.

By 2012, the team was in the top 25 in the world, and caught the attention of Novo Nordisk, a global healthcare company. In December 2012, Novo Nordisk partnered with Team Type 1, creating Team Novo Nordisk.

The team just had one requestall the riders competing must have type 1 diabetes. Southerland complied, and it became the first professional cycling team made entirely of cyclists with the condition.

We went on a recruiting mission and were able to find 17 athletes from around the world to try out with our development team. The rest of cycling world said that it was impossible, that there was no way we could do this, he said. We had kids from 10 different countries, and the majority had never used continuous glucose monitor, let alone race professionally. And we got teeth kicked in.

But the team slowly got better. By 2014, the team had three podium appearances at the Tour of California.

We put our stamp down, and people finally said, Oh, they can race! It was on a global scale, and they saw that, he says.

Since then, theyve created a junior team and training camps for further team development.

We have an amazing family environment. Of the athletes on our professional team, 14/16 came from our pipeline, he says. (At press time, the team was ranked 109th in the world.)

And of course, each athletes health and diabetes management are top priority.

Everyone wears a continuous glucose monitor, and we use technology to see glucose levels at every moment of a bike race, he says. A lot of fans just assume were perfectly controlled diabetics. But we recently started showing our data on social platforms, and it shows that we have the same challenges they do. But we have the technology to take very swift action. When glucose levels are high or low, it negatively impacts performance, so we just have to stay on top of it all the time, adapting to every situation.

So, whats next for the team?

[Want to fly up hills? Climb! gives you the workouts and mental strategies to conquer your nearest peak.]

Its been my dream to get to the Tour de France, says Southerland. 2021 marks the 100th anniversary of insulin being admitted as treatment for diabetes, and I would love for my team to do the Tour de Italia in 2021 to mark it.

While competitively there are big goals, ultimately, he hopes the team inspires awareness and hope in others with diabetes.

This team is the inspiration they need. We stand proud living with type 1 diabetes, he says. We make it about what you can do with diabetes, not what you cant. You can do anything, and I hope that weve inspired those dreams.

Here is the original post:
Meet the Man Who Started the First-Ever All-Diabetes Pro Cycling Team - Bicycling

People living with diabetes are twice as likely to have a heart attack or stroke as people without diabetes thats because people with diabetes, especially those with type 2 diabetes, often have other conditions that contribute to a higher risk of developing cardiovascular disease.

High blood glucose from diabetes can damage your blood vessels and the nerves that control your heart and blood vessels, according to the National Institute of Diabetes and Digestive and Kidney Diseases.

The longer you have diabetes, the higher the chances that you will develop heart disease, according to the institute.

Dr. Nicholas Mills, an internal medicine physician at Memorial Regional Health, said high blood glucose or high levels of sugar in the bloodstream affects every part of the body that has blood supply, including all organ systems.

Thats why its especially important to practice lifestyle habits that lower a persons risk for both diabetes and heart disease. If you already have diabetes, there are steps you can take to reduce your heart disease risk.

What is diabetes?

Diabetes is a condition where ones body is no longer able to properly process sugar in the blood into energy, said Dr. Mills.

This can be caused when the pancreas no longer produces insulin, or the body becomes unable to use insulin efficiently, he said.

Insulin helps the body digest sugars that you eat and drink. Without enough insulin, sugar builds up in your blood, according to the Centers for Disease Control and Prevention (CDC), and over time, that sugar buildup damages nerves, blood vessels, the heart and kidneys.

Dr. Mills said some signs and symptoms of diabetes include feeling thirsty all the time, using the restroom frequently, slow-healing skin wounds, numbness and/or burning in the hands or feet, and changes in vision. Treatment involves lifestyle modifications and medications that will help decrease the amount of glucose (sugar) in the blood.

Why diabetes can lead to heart disease and stroke

Dr. Mills said a non-diabetics body uses blood glucose (sugar and carbohydrates) for energy, and insulin helps the glucose get into the cells to be used as energy. However, in diabetics, the process of moving glucose into the cells is disrupted by either not having enough insulin or not being able to process insulin at the cells, Dr. Mills said.

Because cells always need energy, the liver can use fat and cholesterol as an alternate source of energy, he said. As a result, when blood glucose levels are elevated, cholesterol (lipids) tends to be high. High cholesterol is a known risk factor for cardiovascular disease and stroke.

Prevention

Type 2 diabetes and heart disease are often associated with poor lifestyle habits. Dr. Mills said diets that are high in carbohydrates and sugar, combined with sedentary activity levels, result in poorer health outcomes later on.

Exercise more, sit less. Eat healthier. Drink more water and less sugary drinks, juice, soda and alcohol. Stop smoking, Dr. Mills said. Assess your risk of heart disease with your primary care physician and develop an individualized plan to improve your health and decrease your risks.

The CDC recommends the following steps to lower your risk of diabetes:

Reach a healthy weight. Even a small amount of weight loss can prevent or delay type 2 diabetes in those who are high risk. Ask your doctor what a healthy weight is for you.

Stay physically active. Adults should aim for at least 2 hours and 30 minutes each week (or about 30 minutes per day on most days) of moderate-intensity physical activity, such as brisk walking or cycling. Children should get at least an hour of physical activity each day. Remember: Any physical activity is better than none.

Choose healthy foods. Choose fiber-rich foods, such as fresh vegetables, fruits and whole grains. Avoid foods that are high in sugar, salt and fat.

Quit smoking. If you have diabetes and use tobacco, your risk of heart and blood vessel problems is even greater. Quitting smoking will lower your risk for heart attack, stroke, nerve damage and kidney disease. Take your medicine as directed. It is important that you take any medicine you have been prescribed for your diabetes, such as medicine to control your blood sugar, as directed.

Go here to see the original:
Living Well: The diabetes connection to heart disease and stroke - Craig Daily Press

Click here to read the full article.

Coming in as the seventh-most deadly disease in the United States, diabetes isnt something you want to ignore. But according to research conducted by the American Diabetes Association, 32.3 million Americans had diabetes in 2015 but a whopping 7.2 million of them went diagnosed. What gives?

There are common signs to diabetes, such as frequent urination, increased thirst, weight loss, blurred vision and fatigue, Lucille Hughes, a registered nurse and director of diabetes education for South Nassau Communities Hospital and treasurer of the American Association of Diabetes Educators, tells SheKnows. However, many signs and symptoms of diabetes are vague and can be a symptom of other things.

More from SheKnows

This is especially true for women. While rates of diabetes are relatively equalacross the board, there are several signs of diabetes that are unique to women that you may not have even realized. Especially as November is National Diabetes Month, here are some of the red flags you may be overlooking.

Believe it or not, some urogenital conditions can be signs of diabetes.

Genital symptoms may show up more in women than in men, Dr. Margo Hudson,a Harvard Medical School instructor and physician at the Fish Center for Womens Health at the Brigham and Womens Hospital in Boston, told SheKnows. A typical case is a woman with recurrent yeast infections and recurrent urinary tract infections who goes to the gynecologist and also finds high blood sugar.

Hughes explains that diabetes causes more glucose to be excreted in your urine, leading to these increased tract infections. However, she also points out that some of these symptoms are often misunderstood, especially by older, postmenopausal women.

Menopause brings about changes in a womans body, such as increased weight, vaginal dryness and discomfort during sexual intercourse, Hughes says. Vaginal dryness and discomfort during sexual intercourse are also signs of diabetes, and weight gain puts a woman at risk for diabetes.

As this risk increases as both men and women age, it is important to note these overlapping symptoms.

In addition to vaginal yeast infections, oral yeast infections (AKA cases of oral thrush) are also a common sign to look out for. You may see white patches, experience redness or soreness in your mouth, have swollen red gums or the inner parts of your cheek or experience trouble eating or swallowing because of these infections.

Polycystic ovarian syndrome is a hormonal disorder that occurs when a person with ovaries produces an excess of androgens. If it is not treated, it can lead to a number of complications, including diabetes.

The common denominator of PCOS and diabetes is insulin resistance, a condition that up to 70 percent of people with PCOS exhibit. But while insulin resistance is understood to be a cause of diabetes, medical professionals are not sure whether this condition is a consequence or a cause of PCOS.

With diabetes, we can measure blood sugar and you meet criteria or you dont, Hudson explains. With PCOS, there is no single marker. In my practice, patients are often first diagnosed with diabetes, and it is not until you put together their whole medical history that you realize that the patient also has PCOS.

And since its estimated that almost half of PCOS cases go undiagnosed, it may not be the most recognizable sign of diabetes. But if you have already been diagnosed with PCOS, talk to your health care provider about managing your insulin, and thus mitigating your risk for developing diabetes.

Gestational diabetes is a specific type of diabetes that only appears when people are pregnant, causing high blood sugar levels that could harm both the pregnant person and the baby.

Most women are not aware they have gestational diabetes, Hughes says. Keep in mind that some of the symptoms of diabetes, such as increased thirst, increased urination and fatigue are all common in pregnancy, so they may not trigger an expecting mom to seek medical attention.

According to Hughes, women are especially at risk if they have developed gestational diabetes in a previous pregnancy, if they have previously given birth to a child weighing more than 9 pounds or if their body mass index is over 30. She suggests that all women get screened for gestational diabetes within the first 24 to 28 weeks of their pregnancy to best manage the potential health risks.

Typically, with proper medical attention, these cases of diabetes disappear after the baby is born. Problem solved, right?

Not so fast.

Gestational diabetes is a huge warning sign to patients, Hudson explains. Depending on their ethnicity, these patients have anywhere from a 50 to 70 percent chance of getting diabetes later in life.

While this sounds a little scary to any new moms out there, Hudson points out that this indicator may actually be a good thing, as patients can now understand and manage their risk at an earlier age.

While the signs of diabetes seem to be scattered around different medical specializations, dont be afraid to talk to a medical professional about symptoms that seem to be unrelated.

Whether it is a gynecologist, a [physician assistant] or a nurse practitioner at a walk-in center, a patient needs to tell all of their symptoms, Hudson says. It will not take the system long to figure out what the problem is and who within the system would be the best person the patient needs.

So when in doubt, ask a medical practitioner about any symptoms you think might be a sign of diabetes. The sooner you are diagnosed, the sooner youll be able to start getting the treatment you need.

Sign up for SheKnows' Newsletter. For the latest news, follow us on Facebook, Twitter, and Instagram.

Read the rest here:
These Are the Signs of Diabetes in Women - Yahoo Lifestyle

Nitt Hanprathet,1 Somrat Lertmaharit,1 Vitool Lohsoonthorn,1,2 Thanapoom Rattananupong,1 Palanee Ammaranond,3 Wiroj Jiamjarasrangsi1,2

1Department of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand; 2Department of Preventive and Social Medicine, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok 10330, Thailand; 3Department of Transfusion Medicine, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand

Correspondence: Wiroj JiamjarasrangsiDepartment of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Rama IV Road, Pathumwan, Bangkok 10330, ThailandTel +66 2 256 4000 ext. 3700Fax +662 256 4292Email wjiamja@gmail.com

Purpose: The gender differential evidence of the association between shift work and type 2 diabetes risk remains scarce. This longitudinal study determines whether the association between shift-work exposure and type 2 diabetes risk and abnormal fasting plasma glucose (FPG) differs according to gender; the study aims to find the association between shift work and changes in physiological, behavioral, and psychosocial stress.Patients and methods: This retrospective cohort study was conducted among 5947 workers (4647 female and 1300 male) aged 60 years old in Bangkok, Thailand. Participants required a normal FPG level (<100 mg/dL) at baseline and at least two health check-up results from 2009 to 2016. Shift-work exposure history was assessed using a self-administered questionnaire; FPG levels were measured annually. Cox proportional hazard models were used to assess the aforementioned association.Results: During the follow-up period, 1470 new abnormal FPG and 154 new type 2 diabetes cases developed. Stratified analysis of male workers data revealed an association was significant in the unadjusted model, which tended to be stronger after adjustment for demographic data and the baseline values of anthropometric and biochemical parameters. This was the case both for type 2 diabetes [Hazard Ratio (HR) (95% Confidence Interval (CI))=2.98 (1.585.62)] and abnormal FPG [HR (95% CI)=1.86 (1.432.41)]; this association was less obvious among women.Conclusion: Shift work is a risk factor for type 2 diabetes and abnormal FPG; this risk is gender differential, being more pronounced in men. Preventive measures aiming at ameliorating shift work induced type 2 diabetes risk should pay more attention to men.

Keywords: shift-work exposure, diabetes, abnormal fasting plasma glucose, gender difference, behavioral stress, retrospective cohort study, Cox proportional hazard models

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

See the original post:
Increased Risk Of Type 2 Diabetes And Abnormal FPG Due To Shift Work D | DMSO - Dove Medical Press

Community comes together to help find a cure for diabetes

IMPERIAL, Calif. - Dozens filled the track at Imperial Valley College on Saturday,for the inaugural "Juvenile Diabetes Research Foundation One Walk",to help raise awareness for those battling diabetes.

Matthew Jaime, one of the event organizers saidImperial County has one of the highest rate of incidences involving diabetes.

They hope the walk will have an impact onthe current health care for local diabetics.

"An event like this is a testament to the fact that we can make improvements in the way that we approach care to diabetes here in the Imperial Valley. And that just because we're our own little community out here in the desert doesn't mean that we can't bring the resources down to our people. And this event is a testament to that," said Jaime.

Funds raised at the walk go towards research to find a cure for type one diabetes. For a link to local agencies that help residents prevent diabetes you can click here.

The rest is here:
Community comes together to help find a cure for diabetes - KYMA

LAS VEGAS An investigational agent, bimagrumab (Novartis) which was originally being tested to see if it would increase lean muscle mass in people with sarcopenia is effective and safe for weight loss, according to preliminary results from a study in patients with obesity and type 2 diabetes.

Laura A. Coleman, PhD, RD, a researcher at Novartis in Cambridge, Massachusetts, presented intriguing phase 2 trial findings with this activin receptor antagonist here in a late-breaking research forum before the start of Obesity Week 2019.

The investigators randomly assigned 75 patients with obesity and type 2 diabetes to receive monthly injections of the drug, or placebo, plus twice monthly visits with a registered dietitian.

"Neither group really changed their diet" or met their goal of a 500 calorie/day deficit, Coleman reported.

However, at 48 weeks, on average, patients in the treated group had a 21% drop in body fat mass (-7.5 kg, or -16.5 lb), a 6.5% reduction (-5.9 kg) in body weight, and a 3.6% increase (1.7 kg) in lean body mass.

In the placebo group, patients had a 0.5% drop in body fat mass (-0.2 kg), a 0.8% fall in body weight (-0.8 kg), and a loss of lean body mass of 0.8% (-0.4 kg).

Invited to comment, session chair Lee M. Kaplan, MD, PhD, president of the Obesity Society, pointed out that by gaining lean muscle mass, the participants receiving bimagrumab were also losing more fat mass, with the resulting net weight loss of 6.5%, which is similar to that seen with other anti-obesity medications that suppress appetite.

"What it suggests," Kaplan told Medscape Medical News, "is that there may be a completely new mechanism at play here, because in this situation, patients weren't eating less but [those taking bimagrumab]were losing the same amount of weight as [those taking] other drugs that work by causing patients to eat less."

"Is this going to be the kind of complementary drug with a different mechanism that's going to augment the effects of other drugs?" wondered Kaplan, the director of the Obesity, Metabolism & Nutrition Institute at Massachusetts General Hospital in Boston. He was not involved in the current study but has previously served as a scientific consultant to Novartis.

Research is suggesting that there are "multiple subtypes of obesity, like cancer," he added, saying he believes what will eventually be required are "multiple drugs with multiple mechanisms, for multiple subtypes of obesity."

Coleman told Medscape Medical News: "It's exciting that we were able to achieve this profound weight loss with an increase in lean mass in our subjects, along with metabolic benefits."

Coleman explained to delegates that data from a prior phase 2 trial of patients with sarcopenia showed that bimagrumab increased lean muscle mass, but this did not translate into an improvement in function which had been the primary efficacy endpoint of the study so Novartis stopped work on that indication.

Researchers had observed, however, that the drug decreased fat mass in humans, an effect which had not been seen in animal studies.

To further investigate this, researchers first performed a study in 16 patients with prediabetes, which showed that bimagrumab reduced body fat.

Building on this, the current phase 2 study aimed to determine the safety and efficacy of bimagrumab on body composition and glycemic control in adults with obesity and type 2 diabetes.

The investigators enrolled 75 patients who had a BMI of 28 to 40 kg/m2, and an A1c of 6.5% to 10% at 8 sites in the UK and 1 site in the US.

Most patients were were receiving metformin (85%), some metformin plus a DPP-4 inhibitor (4%), while 11% were not on any antidiabetic medication.

Patients in both the bimagrumab and placebo groups had a mean age of about 60 and a mean A1c of about 8%.

However, there were more women in the bimagrumab group than in the placebo group (62% vs 32%) and they had a lower mean weight (90.1 kg vs 98.9 kg) and BMI (32.7 vs 33.1), both of which were adjusted for in the subsequent calculations.

In addition to the frequent visits with a dietitian, all patients were advised to follow a walking program as recommended by the American Diabetes Association.

The patients received subcutaneous injections of 10 mg/kg bimagrumab or placebo every 4 weeks, for 48 weeks, with the last dose at week 44.

Adverse events were primarily mild (such as diarrhea) and transient, and most occurred with the early doses.

At 48 weeks, 96% of the patients receiving bimagrumab had lost at least 5% of their total body fat, and 77% had lost at least 15% of their total body fat.

In terms of weight loss, 66% of those on the active drug had lost at least 5% of their total body weight and 12% had lost at least 15% of their body weight.

A1c was decreased by 0.76% in the bimagrumab group vs 0.04% in the placebo group.

And this despite the fact that those "in the placebo group received more than standard of care," Coleman stressed.

"Nobody's insurance pays for a dietitian every 2 weeks for a year," she said,"and the weight loss diet didnt work."

36th ASMBS Annual Meeting at Obesity Week 2019: Presented November 4, 2019.

For more diabetes and endocrinology news, follow us on Twitter and on Facebook

Continued here:
Investigational Drug Promising in Obese Patients With Diabetes - Medscape

Type 2 diabetes causes the body not to respond to insulin properly, and it may not produce enough, which leads to blood sugar levels becoming too high. If the condition is left untreated, a number of problems can occur, including kidney failure, nerve damage, heart disease and stroke, so doing what you can to control blood sugar levels and prevent the condition is very important.

Regularly eating a poor diet is one of the risk factors for developing type 2 diabetes, so making changes to the food you eat is recommended.

The NHS says theres nothing you cannot eat if you have type 2 diabetes, but certain foods should be limited.

It states: Eat a wide range of foods - including fruit, vegetables and some starchy foods like pasta, keep sugar, fat and salt to a minimum, and eat breakfast, lunch and dinner every day - do not skip meals.

But individual food and drink have also been found to hold blood sugar lowering properties.

READ MORE:Type 2 diabetes: The simple lifestyle change to put the condition in remission

One food which has become increasingly popular to have at breakfast and been shown to prevent diabetes is avocado.

Researchers have shown how a compound found only in avocados can inhibit cellular processes int he pancreas that normally lead to diabetes.

Commenting on the research, Dr Sarah Brewer, whos on the CuraLife advisory board, said: While avocado is often thought of as a vegetable, it is in fact a fruit. Unlike most other fruit, avocados are low in sugar and rich in oils.

As much as 30 percent of the weight of avocado pulp consists of oils, of which 80 percent are beneficial monounsaturated fats similar to those found in olive oil. Although they have a high energy content, avocados also have one of the highest protein content of any fruit.

DON'T MISS

Many people avoid eating avocados because of their high fat and calorie content.

But Dr Brewer advised: But they can aid weight loss and are beneficial if you have diabetes.

The main sugar found in avocado is a unique form known as D-mannopheptulose which does not act like a conventional sugar. It helps to satisfy sensations of hunger and supports improved blood glucose control and weight management.

Together with their protein content, avocados are particularly filling so you tend to eat less overall.

The monounsaturated fat content of avocado also has benefits for glucose control. Research shows that replacing a low-fat, complex-carbohydrate rich diet with an avocado-rich diet can significantly improve blood glucose levels in people with type 2 diabetes.

The research from the University of Guelph suggests avocado may even protect against type 2 diabetes by inhibiting some of the abnormal cell metabolic processes that occur in diabetes.

Dr Brewer explained more about the findings: A particular molecule that is unique to avocados, and known as avocatin B can reduce insulin resistance in skeletal muscle and pancreas cells.

Healthy volunteers who took avocatin B extracts as a dietary supplement lost some weight while continuing to eat their normal diet, and no safety concerns were highlighted. Trials in people with type 2 diabetes are now planned.

Pharmacists and other healthcare professionals are providing increasing support for people who prefer to take more control over their own health.

And Dr Brewer said healing systems such as Ayurveda, which uses more natural approaches such as herbal medicines, are also increasing in popularity.

She said: Medicine is moving away from the old paradigm of diagnose and treat towards one of self-help and prevent.

Dr Brewer also recommended: The blend of 10 Ayurvedic herbs within CuraLin have a range of beneficial effects on glucose control and metabolism.

As a result, users report that their glucose control quickly improves and, in some cases, normalises within four weeks. Users also report reduced cravings for sweet food, and experience improved energy, sleep and general quality of life.

See original here:
Type 2 diabetes: Eating this fruit for breakfast could lower blood sugar - Express

When a 41-year-old African-Canadian man who enjoyed long bike rides on his fixie and pick-up basketball and whose go-to snack was broccoli buds was diagnosed with type 1 diabetes, it obviously came as a surprise.

Oddly, it was a welcome one.

I really thought I was dying, says Daaki Meade, So, when they told me it was diabetes, I was actually relieved.

Daakis symptoms began in 2016. Suddenly, he found it difficult to lift things, and when he stood up too quickly he got head rushes.

Walking home with groceries, I was finding it difficult to carry the bag, he recalls, I had to stop twice in a two-block radius. I was so tired, and it was so heavy.

Daakis appetite decreased but he was thirsty all the time and urinated frequently. He was anxious, depressed and sleeping a lot. He lost weight rapidly, dropping from 250 to 200 pounds over only a few weeks. Soon he was bedridden.

It really seemed like I could lose him, recalls his fianc, Arlee-Anne Goldson. She called 911.

When the ambulance arrived, Daaki couldnt walk. The paramedics brought him to the Schwartz/Reisman Emergency Centre at Mount Sinai Hospital, where tests revealed his blood sugar levels were four times higher than normal a telltale sign of diabetes.

In fact, it was severe onset type 1 diabetes, a disease that usually presents under the age of 35.

Daaki was admitted to the Intensive Care Unit while his care team assessed the disease.

Read more from the original source:
The Changing Face of Diabetes - yorkregion.com

AMA recently published a detailed study of over 180+ pages in its repository on Neuropathy Pain Treatment market covering interesting aspects of market with supporting development scenario till 2025. The study provides market size break-up by revenue and volume* for emerging countries and important business segments along with commentary on trending factors, growth drivers. Profiled players in study from the coverage used under bottom-up approach are Pfizer [United States], Depomed [United States], Eli Lilly [United States], Endo [Ireland], Grnenthal Group [Germany], Arbor Pharmaceuticals [United States], Astellas Pharma Inc. [Japan], Biogen Inc. [United States], Baxter Healthcare Corporation [United States], Sanofi S.A [France], Abbott Laboratories [United States], AstraZeneca [United Kingdom], Johnson & Johnson Services Inc. [United States], GlaxoSmithKline plc [United Kingdom], Depomed Inc. [United States].

Neuropathy pain treatment involves cure of pain associated with somatosensory nervous system. As of 2018 data, 18% of Canadian population, 7% of French and over 4% of United Kingdom population experience pain of neuropathic origin. With growing geriatric population across the world, the number of neuropathic pain causing diseases will increase significantly, thus, giving pain treatment services offering companies an opportunity to explore in untapped market.

Next step one should take to boost sales? Track latest strategic steps and current scenario analysis of the market @ https://www.advancemarketanalytics.com/sample-report/32655-global-neuropathy-pain-treatment-market

Market Segmentation

by Type (Peripheral Neuropathy, Entrapment Neuropathy, Post Traumatic Neuropathy, Trigeminal Neuralgia, Post Herpetic Neuralgia (PHN), Phantom Limb Pain, Others), Indication Type (Diabetic Neuropathy, Trigeminal Neuralgia, Post-herpetic Neuralgia, Chemotherapy-induced Peripheral Neuropathy, Others.), Treatment (Medication, Multimodal Therapy), Distribution Channels (Pharmacies, Retail Pharmacies, Online Pharmacies), End-user (Hospitals, Clinics, Research Organizations), Diagnosis (Imaging, Blood Tests)

Make an enquiry before buying this Report @ https://www.advancemarketanalytics.com/enquiry-before-buy/32655-global-neuropathy-pain-treatment-market

Whats Trending in Market:

Increasing Demand of Generic Drugs

Emergence of Innovative Pain Treatment Methods Such as Use of Electrical Stimulation Devices, Stem Cell Procedures and Others

Growth Drivers: Rising Geriatrics Population Across the World

Growing Number of Cancer and Diabetes Cases

Restraints: High Cost of Neuropathy Pain Treatment

Lack of Health Infrastructure and Budgets in Emerging Countries

View Detailed Table of Content @ https://www.advancemarketanalytics.com/reports/32655-global-neuropathy-pain-treatment-market

Country level Break-up includes:

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Netherlands, Switzerland, Nordic, Others)

Asia-Pacific (Japan, China, Australia, India, Taiwan, South Korea, Middle East & Africa, Others)

Try a limited scope research document specific to Country or Regional matching your objective.

GET FULL COPY OF United States Neuropathy Pain Treatment market study @ USD 2000

And, Europe Neuropathy Pain Treatment market study @ USD 2500

Strategic Points Covered in Table of Content of Global Neuropathy Pain Treatment Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Neuropathy Pain Treatment market

Chapter 2: Exclusive Summary the basic information of the Neuropathy Pain Treatment Market.

Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges of the Neuropathy Pain Treatment

Chapter 4: Presenting the Neuropathy Pain Treatment Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.

Chapter 5: Displaying the by Type, End User and Region 2013-2018

Chapter 6: Evaluating the leading manufacturers of the Neuropathy Pain Treatment market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile

Chapter 7: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions.

Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Buy this report @ https://www.advancemarketanalytics.com/buy-now?format=1&report=32655

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Contact Us:

CRAIG FRANCIS (PR & Marketing Manager)

[emailprotected]

Ph: +1 (206) 317 1218

Go here to see the original:

Neuropathy Pain Treatment Market Set For Rapid Growth and Trend | Statistics Analysis and Opportunities 2024 - News Description

Rising Prevalence of Cancer Worldwide to Promote Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Growth

A painful dysfunction of the somatosensory nervous system in the body is called chemotherapy-induced peripheral neuropathy or CIPN. It is estimated that chemotherapy-induced peripheral neuropathy affects an estimate of 68.0% patients who undergo within their first month of diagnosis, among which 30% patients are affected on a chronic basis. The rising prevalence of chronic diseases is promoting the growth of Chemotherapy Induced Peripheral Neuropathy Treatment market. According to Fortune Business Insights, the market for Chemotherapy Induced Peripheral Neuropathy Treatment is anticipated to rise exponentially with increasing prevalence of diabetes worldwide.

Browse Complete Report [emailprotected] https://www.fortunebusinessinsights.com/industry-reports/chemotherapy-induced-peripheral-neuropathy-treatment-market-101218

Rising Prevalence of Cancer to Help Generate High Chemotherapy Induced Peripheral Neuropathy Treatment Market Revenues

The increasing prevalence of chronic diseases such as diabetes and cancer are the major factors promoting the Chemotherapy Induced Peripheral Neuropathy Treatment market. The surge in adoption of chemotherapy is significantly helping to increase the prevalence of peripheral neuropathy. Additionally, lack of proper guidelines about chemotherapy heightens the chance of additional incidence of peripheral neuropathy. This is expected to bode well for generating greater percentages of the global Chemotherapy Induced Peripheral Neuropathy Treatment market share.

However, the market may face certain challenges in terms of the lack of awareness about symptoms of chemotherapy-induced peripheral diagnosis, especially in developing nations. Such challenges may hamper the global Chemotherapy Induced Peripheral Neuropathy Treatment market growth in the forecast period.

Get PDF Brochure of this [emailprotected] https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/chemotherapy-induced-peripheral-neuropathy-treatment-market-101218

Some of the companies operating in the global Chemotherapy Induced Peripheral Neuropathy Treatment market include:

Improving Healthcare Infrastructure and Medical Facilities of Developing Nations to Help Asia Pacific Market Grow Significantly

According to the Center for Diseases Control and Prevention (CDC), ABOUT 1,633,390 new cancer cases were reported in the U.S. in 2015, among which, an estimated 595,919 people died of cancer. As per the geographical categorization, North America is currently holding a significant share in the global Chemotherapy Induced Peripheral Neuropathy Treatment market and is anticipated to continue doing the same in the forecast period as well. This is attributable to the rising prevalence of cancer which is further propelling the demand for chemotherapy treatment by patients and their family members.

On the other side, the global Chemotherapy Induced Peripheral Neuropathy Treatment market in Asia Pacific and Europe will also witness remarkable growth rate during the forecast period owing to improving healthcare infrastructure and medical facilities, especially in the developing nations.

Strategic Partnerships to Help Market Players Gain Strong Foothold in Market

As per the report, the global Chemotherapy Induced Peripheral Neuropathy Treatment market highlights some of the major market shareholders significantly driving the market. These companies are mentioned below

Manufactures continue to focus on new product launches and merger and acquisition strategies to increase their customer base and broaden product portfolio. These manufacturers produce new therapeutic methods to maintain a strong foothold in the market. Some of the recent development made by companies are mentioned below

More Trending Topics From Fortune Business [emailprotected]

U.S. Biosimilars Market 2019 Global Technology, Consumption, Segmentation, Growth, Development, Trends and forecasts to 2026

Mass Spectrometer Market Size Overview by Share, Growth Factor, Industry Trends, and Analysis to 2026

About Us

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Chemotherapy Induced Peripheral Neuropathy Treatment Market to Generate Higher Revenues by Entering into Strategic Collaborations says Fortune Business Insights

The rest is here:

Chemotherapy Induced Peripheral Neuropathy Treatment Market to Generate Higher Revenues by Entering into Strategic Collaborations says Fortune...

The Global Neuropathy Pain Treatment Market is the increasing incidence of neuropathic pain caused by damage or

disease affecting the somatosensory nervous system. Growing awareness among patients and increase in the demand for generic drugs boost the market growth. However, severe side effects of opioids and steroids and rising costs of branded drugs might hamper the market growth

Buy one-Get one: https://www.orianresearch.com/checkout/956157

[Buy this report and get another report of the same price for free. offer for limited period only].

Based on type, the market is divided into:

Based on application, the market is divided into:

Moreover, the market is classified based on regions and countries as follows:

For More Info, Get Sample Report Here @ https://www.orianresearch.com/request-sample/956157

Key Market Players:

Key Benefits of the Report:

Target Audience:

GET Flat 40% Discount https://www.orianresearch.com/discount/956157

[Avail flat 40% discount on this report. offer for limited period only]

Table of Contents

Customization Service of the Report:

Orian Research provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

About Us

Orian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the worlds most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

Contact Us:

Ruwin Mendez

Vice President Global Sales & Partner Relations

Orian Research Consultants

US: +1 (415) 830-3727 | UK: +44 020 8144-71-27

Email: [emailprotected]

Website: http://www.orianresearch.com

See the original post:

Global Neuropathy Pain Treatment Profiling Industry 2019 Market Share, Regional Analysis, Growth Insights, Leading Companies, End Users and Forecast...

Diabetic Peripheral NeuropathyMarket

Diabetic PeripheralNeuropathy-Epidemiology Forecasting Intelligence report provides acomprehensive analysis of the Diabetic Peripheral Neuropathy epidemiology,providing the historical, current, and forecasted data for the United States,European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) andJapan during the period from 2018-2028.

Our epidemiology services include:

Incidence andprevalence Diagnosis rate, treatment rate and mortality patterns Epidemiology-based forecasting and disease trends Size of different patient segments in a disease area Population based: disease occurrence, co-morbidities and treatment patterns Geographic Regional Ethnic differences

Along with the epidemiological data, the reportalso includes:

Disease overview,causes, symptoms, classification, risk factor, pathophysiology, diagnosis andtreatment Patient treatment journey Treatment algorithm and guidelines Assesses the disease risk and burden Highlights the unmet needs Market driver and barrier Growth opportunities and market trend analysis

Methodology

This report isbuilt using data and information sourced from proprietary databases, primaryand secondary research and in-house Epidemiology Forecast model analysis by ateam of industry experts. To generate accurate patient population estimates, utilizes a combination ofseveral world class sources that deliver the most up to date information frompatient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have beenidentified in the report.

Note:

Systematic review ofthe epidemiological literature is also provided for full transparency intoresearch and methods. This report can be delivered to the clients within 4-5business days.

Request customize:-

If you wish to find more details ofthe report or want a CustomizationPlease contacts us. You can get adetailed of the entire research here.

Ozone Market Reports is committed towards delivering intensiveresearch based analysis reports, enabling clients to easily make fact-baseddecisions. We also have with us the facility of our innovatively designed anddeveloped data processing and analysis division.

Ozone Market Reports is a research-based consulting firmspecializing in getting research inputs and using them appropriately in themarketing planning process. In saying this, we are trying to convey that wealways attempt to interpret the research data from the viewpoint ofrecommending action priorities both short-term and long-term. To this end, wehave put together a team that understands not only research techniques, butalso branding concepts in depth.We believe our people are our clientsbiggest assetshence we do our best to recruit multi-skilled individuals,and then give them an environment where they can think and ideate freely.

We offer various services for our clients to help them choosewhats most relevant and best for them required for their business.

Contact Us:

Name: Steven Samuel

Email info@ozonemarketreports.com

Phone +91 9370882135

Website: https://www.ozonemarketreports.com/

Post Views: 70

Read the original post:

Diabetic Peripheral Neuropathy Market - Growth, Future Prospects, and Competitive Analysis 2028 - Market Tribunal